Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin

by Evelyn M. Cov és-Datson, Julie Dyall, Lisa Evans DeWald, Steven R. King, Derek Dube, Maureen Legendre, Elizabeth Nelson, Kelly C. Drews, Robin Gross, Dawn M. Gerhardt, Lisa Torzewski, Elena Postnikova, Janie Y. Liang, Bhupal Ban, Jagathpala Shetty, Lisa E. Hensley, Peter B. Jahrling, Gene G. Olinger Jr., Judith M. White, David M. Markovitz Ebolaviruses cause an often rapidly fatal syndrome known as Ebola virus disease (EVD), with average case fatality rates of ~50%. There is no licensed vaccine or treatment for EVD, underscoring the urgent need to develop new anti-ebolavirus agents, especially in the face of an ongoing outbreak in t he Democratic Republic of the Congo and the largest ever outbreak in Western Africa in 2013–2016. Lectins have been investigated as potential antiviral agents as they bind glycans present on viral surface glycoproteins, but clinical use of them has been slowed by concerns regarding their mitogenic ity, i.e. ability to cause immune cell proliferation. We previously engineered a banana lectin (BanLec), a carbohydrate-binding protein, such that it retained antiviral activity but lost mitogenicity by mutating a single amino acid, yielding H84T BanLec (H84T). H84T shows activity against viruses co ntaining high-mannoseN-glycans, including influenza A and B, HIV-1 and -2, and hepatitis C virus. Since ebolavirus surface glycoproteins also contain many high-mannoseN-glycans, we assessed whether H84T could inhibit ebolavirus replication. H...
Source: PLoS Neglected Tropical Diseases - Category: Tropical Medicine Authors: Source Type: research

Related Links:

Thursday is the deadline for health care workers to get at least their first dose of coronavirus vaccine in much of the country, as the Biden administration’s mandate starts to take effect.
Source: Washington Post: To Your Health - Category: Consumer Health News Authors: Source Type: news
The CDC contacted pharmacies on Wednesday to reinforce the message that people with moderate to severe immune suppression should receive a fourth COVID-19 vaccine.WebMD Health News
Source: Medscape Infectious Diseases Headlines - Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news
GAO criticizes the response to emergencies over four administrations, including coronavirus, Ebola and Zika, as well as extreme weather events.
Source: Washington Post: To Your Health - Category: Consumer Health News Authors: Source Type: news
The U.S. Army is working on a pan-coronavirus vaccine that will be effective against all future strains of the virus, and could even prevent future pandemics from occuring.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Dr. Hultin ’s discovery of a frozen victim of the 1918 pandemic gave scientists the opportunity to map the virus’s genetic material.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Influenza Epidemic (1918-19) Deaths (Obituaries) Genetics and Heredity Hultin, Johan (1924-2022) Source Type: news
THURSDAY, Jan. 27, 2022 -- A new policy has simplified the Advisory Committee on Immunization Practices (ACIP) pneumococcal vaccination recommendations; the updated recommendations are published in the Jan. 28 issue of the U.S. Centers for Disease...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
THURSDAY, Jan. 27, 2022 -- Receipt of a third COVID-19 mRNA vaccine dose is associated with increased vaccine effectiveness against COVID-19 hospitalization, according to research published in the Jan. 28 issue of the U.S. Centers for Disease...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
A Boston hospital is defending itself after a man’s family claimed he was denied a new heart for refusing to be vaccinated against COVID-19
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
In this study, we evaluated ATA as a potential antiviral drug against ZIKV replication. The antiviral activity of ATA against ZIKV replication in vitro showed median inhibitory concentrations (IC50) of 13.87 ± 1.09 μM and 33.33 ± 1.13 μM in Vero and A549 cells, respectively; without showing any cytotoxic effect in both cell lines (median cytotoxic concentration (CC50)> 1,000 μM). Moreover, ATA protected both cell types from ZIKV-induced cytopathic effect (CPE) and apoptosis in a time- and concentration-dependent manner. In addition, pre-treatment of Vero cells with ATA for up to 72 h also resulted...
Source: Frontiers in Microbiology - Category: Microbiology Source Type: research
Conclusion This study has identified a substance in the mucus secreted by a south Indian frog which can kill certain types of flu virus. Researchers often turn to natural substances with known health-giving properties to find potential new drugs for humans. For example, aspirin was developed based on a compound found in willow bark – which had been used in traditional medicine for hundreds of years. Some other drugs – such as some chemotherapy and anticlotting drugs – have also been developed from chemicals found in plants. By isolating the substances that have an effect the researchers can make sure...
Source: NHS News Feed - Category: Consumer Health News Tags: Heart/lungs Medication Medical practice Source Type: news
More News: African Health | Carbohydrates | Congo Health | Ebola | Ebola Vaccine | Genetics | Hepatitis | Hepatitis C | Hepatitis Vaccine | Influenza | Influenza Vaccine | Outbreaks | Tropical Medicine | Vaccines